1. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis. Issue 6 (June 2022) Authors: Baker, Jonathan R; Mahdi, Mahdi; Nicolau, Dan V; Ramakrishnan, Sanjay; Barnes, Peter J; Simpson, Jodie L; Cass, Steven P; Russell, Richard E K; Donnelly, Louise E; Bafadhel, Mona Journal: Lancet Issue: Volume 10:Issue 6(2022) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Issue 7 (July 2021) Authors: Ramakrishnan, Sanjay; Nicolau, Dan V; Langford, Beverly; Mahdi, Mahdi; Jeffers, Helen; Mwasuku, Christine; Krassowska, Karolina; Fox, Robin; Binnian, Ian; Glover, Victoria; Bright, Stephen; Butler, Christopher; Cane, Jennifer L; Halner, Andreas; Matthews, Philippa C; Donnelly, Louise E; Simpson, ... Journal: Lancet Issue: Volume 9:Issue 7(2021) Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗